Skip to content

Application and exploration of OCTA in optic disc neovascular disease

Application and exploration of OCTA in optic disc neovascular disease

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050918
Enrollment
Unknown
Registered
2021-09-08
Start date
2021-10-11
Completion date
Unknown
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

case series:None

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years with diabetes; 2. No opacity of the refractive medium and miosis that affect the fundus examination; 3. According to fundus photography or OCT or FA clinical diagnosis of optic disc neovascularization.

Exclusion criteria

Exclusion criteria: 1. Active eye infection (such as blepharitis, keratitis, scleritis, conjunctivitis, etc.) in either eye; 2. In addition to diabetes, the target eye also suffers from other ophthalmic conditions (such as retinal vein occlusion (RVO), CNV, retinal detachment, macular hole, macular retinal traction, epiretinal membrane, etc.); 3. The researcher believes that the target eye cataract may affect the judgment of the examination or test results, or require surgical treatment within the next 6 months.

Design outcomes

Primary

MeasureTime frame
New blood vessel area;

Countries

China

Contacts

Public ContactWang Xiangning

Shanghai Sixth People's Hospital

xnwang21@163.com+86 18930170516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026